It’s a known problem, but treatment hasn’t improved in 20 years. Experts say it’s time for protocolized systems of care, they ...
When it comes to getting STEMI patients treated quickly, US hospital systems appear to be falling short in recent years, according to an analysis of the Get With The Guidelines Coronary Artery Disease ...
Therapy initiated within national treatment-time goals set a decade ago for patients with ST-segment elevated myocardial infarction (STEMI) remains associated with improved survival in recent years.
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — New, 2-year data from a global registry enrolling patients with STEMI in low- and middle-income ...
Prehospital pulse-dose glucocorticoid treatment in patients with ST-segment elevation myocardial infarction (STEMI) does not reduce the final infarct size at 3 months but may improve acute outcomes ...
Despite underrepresentation in clinical trials of acute coronary syndrome treatments, a recent study suggests treatment strategies and outcomes in chronic kidney disease patients with ST-elevation ...
Newly Released BMJ Publication Demonstrates Improved Acute Stroke/STEMI Treatment Times with Pulsara
Australian-based healthcare real-world feasibility study finds improved communication and faster patient care timelines when using Pulsara. Our research provides evidence that Pulsara can be used as a ...
In a recent study published in the European Heart Journal - Quality of Care and Clinical Outcomes, researchers predicted long-term health consequences and expenses associated with ST-elevation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results